S2Medical AB Class B (S21) Ratios
S2Medical AB Class B Ratios
DE:S21's free cash flow for Q2 2026 was $84.50K. For the 2026 fiscal year, DE:S21's free cash flow was increased by $0.00 and operating cash flow was $169.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.56 | 0.92 | 0.44 | 0.65 | 1.08 |
| Quick Ratio | 0.51 | 0.65 | 0.18 | 0.30 | 0.78 |
| Cash Ratio | 0.13 | 0.16 | 0.08 | 0.20 | 0.63 |
| Solvency Ratio | -1.25 | 1.08 | -1.06 | -1.54 | -1.27 |
| Operating Cash Flow Ratio | 0.10 | 0.50 | -0.84 | -1.54 | -1.31 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -94.68 |
| Net Current Asset Value | $ -3.07M | $ -496.76K | $ -11.12M | $ -6.29M | $ 1.27M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.71 | 1.53 | 12.91 | 3.58 | 2.02 |
| Debt Service Coverage Ratio | -234.17 | 341.15 | -1.82 | -15.91 | -42.05 |
| Interest Coverage Ratio | -446.83 | 289.55 | -2.05 | -15.66 | -81.49 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.05 | 0.03 | 0.01 |
| Net Debt to EBITDA | 0.65 | -0.15 | 0.11 | 0.14 | 0.50 |
| Profitability Margins | |||||
| Gross Profit Margin | -14.39% | 94.86% | 72.25% | 110.60% | 92.17% |
| EBIT Margin | -18.67% | 38.85% | -218.95% | -592.88% | -257.62% |
| EBITDA Margin | -9.78% | 45.77% | -194.08% | -564.56% | -243.22% |
| Operating Profit Margin | -18.67% | 38.85% | -218.95% | -592.88% | -257.62% |
| Pretax Profit Margin | -70.27% | 38.72% | -325.73% | -630.73% | -260.78% |
| Net Profit Margin | -70.27% | 38.72% | -325.73% | -630.73% | -260.78% |
| Continuous Operations Profit Margin | -70.27% | 32.28% | -325.73% | -630.73% | -260.78% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 376.43% | 99.65% | 148.76% | 106.38% | 101.23% |
| Return on Assets (ROA) | -59.71% | 31.90% | -106.07% | -116.46% | -67.66% |
| Return on Equity (ROE) | -102.18% | 48.90% | -1369.60% | -416.69% | -136.77% |
| Return on Capital Employed (ROCE) | -27.15% | 49.06% | -920.65% | -391.68% | -135.11% |
| Return on Invested Capital (ROIC) | -27.16% | 48.57% | -920.65% | -391.68% | -133.23% |
| Return on Tangible Assets | -242.37% | 95.04% | -242.27% | -224.54% | -111.52% |
| Earnings Yield | -110.09% | 98.17% | -311.54% | -81.60% | -8.51% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.22 | 6.41 | 4.83 | 2.82 | 5.33 |
| Payables Turnover | 18.11 | 2.15 | 0.56 | -0.28 | 0.61 |
| Inventory Turnover | 41.75 | 0.46 | 0.37 | -0.08 | 0.13 |
| Fixed Asset Turnover | 71.09 | 37.08 | 9.32 | 3.94 | 4.42 |
| Asset Turnover | 0.85 | 0.82 | 0.33 | 0.18 | 0.26 |
| Working Capital Turnover Ratio | -8.06 | -2.57 | -0.80 | -1.86 | 0.63 |
| Cash Conversion Cycle | 28.19 | 689.14 | 394.51 | -3277.24 | 2269.73 |
| Days of Sales Outstanding | 39.60 | 56.98 | 75.54 | 129.34 | 68.51 |
| Days of Inventory Outstanding | 8.74 | 801.79 | 974.05 | -4713.94 | 2799.58 |
| Days of Payables Outstanding | 20.15 | 169.63 | 655.08 | -1307.36 | 598.36 |
| Operating Cycle | 48.34 | 858.77 | 1049.59 | -4584.61 | 2868.09 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | 0.01 | -0.10 | -0.41 | -0.34 |
| Free Cash Flow Per Share | -0.00 | 0.00 | -0.11 | -0.44 | -0.39 |
| Dividend Paid and CapEx Coverage Ratio | 1.00 | 4.92 | -14.30 | -14.81 | -6.35 |
| Capital Expenditure Coverage Ratio | 1.00 | 4.92 | -14.30 | -14.81 | -6.35 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -94.68 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.21 | -2.37 | -6.02 | -2.55 |
| Free Cash Flow Yield | -14.70% | 42.32% | -242.49% | -83.19% | -9.65% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.91 | 1.02 | -0.32 | -1.23 | -11.75 |
| Price-to-Sales (P/S) Ratio | 0.64 | 0.39 | 1.05 | 7.73 | 30.63 |
| Price-to-Book (P/B) Ratio | 0.93 | 0.50 | 4.40 | 5.11 | 16.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.80 | 2.36 | -0.41 | -1.20 | -10.36 |
| Price-to-Operating Cash Flow Ratio | 13.58 | 1.88 | -0.44 | -1.28 | -11.99 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.01 | 0.00 | -0.04 | -1.94 |
| Enterprise Value Multiple | -5.88 | 0.71 | -0.43 | -1.23 | -12.10 |
| Enterprise Value | 8.26M | 4.87M | 5.77M | 32.37M | 226.57M |
| EV to EBITDA | -5.88 | 0.71 | -0.43 | -1.23 | -12.10 |
| EV to Sales | 0.58 | 0.33 | 0.83 | 6.93 | 29.43 |
| EV to Free Cash Flow | -6.13 | 1.96 | -0.33 | -1.08 | -9.95 |
| EV to Operating Cash Flow | 12.24 | 1.56 | -0.35 | -1.15 | -11.52 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.07 | -0.07 | 0.05 |
| Shareholders’ Equity Per Share | 0.01 | 0.02 | 0.01 | 0.10 | 0.25 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.06 | -0.01 |
| Revenue Per Share | 0.02 | 0.03 | 0.04 | 0.07 | 0.13 |
| Net Income Per Share | -0.01 | 0.01 | -0.14 | -0.43 | -0.34 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 3.76 | 1.00 | 1.49 | 1.06 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.09 | 0.13 | 0.05 |
| SG&A to Revenue | 0.00 | 1.01 | 0.00 | 0.00 | 1.59 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.07 | 0.54 | 1.08 | 1.02 | 0.99 |
Currency in SEK
